微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | -10.15% | 0.49% | -59.84% | 50/52 | 3.3% | 澳洋健康 | 25.95% | 行业排名> |
| 2025-06-30 | -6.35% | -6.37% | -82.47% | 51/52 | 1.68% | 澳洋健康 | 19.74% | 行业排名> |
| 2025-03-31 | -3.48% | -66.51% | 80.35% | 48/52 | 0.99% | 澳洋健康 | 12.87% | 行业排名> |
| 2024-12-31 | -17.71% | -180.22% | -73.63% | 48/52 | -1.11% | 澳洋健康 | 28.53% | 行业排名> |
| 2024-09-30 | -10.2% | -207.23% | -70.85% | 50/52 | 3.33% | 澳洋健康 | 34.16% | 行业排名> |
| 2024-06-30 | -5.97% | -172.6% | -185.65% | 50/52 | 1.9% | 澳洋健康 | 30.56% | 行业排名> |
| 2024-03-31 | -2.09% | -42.18% | 66.93% | 45/52 | 1.19% | 澳洋健康 | 28.14% | 行业排名> |
| 2023-12-31 | -6.32% | -427.46% | -90.36% | 43/52 | 2.79% | 澳洋健康 | 39.54% | 行业排名> |
| 2023-09-30 | -3.32% | -270.26% | -51.6% | 46/52 | 6.82% | 澳洋健康 | 61.84% | 行业排名> |
| 2023-06-30 | -2.19% | -293.81% | -48.98% | 45/52 | 1.93% | 澳洋健康 | 48.34% | 行业排名> |
| 2023-03-31 | -1.47% | -213.08% | -176.17% | 44/52 | 2.58% | 澳洋健康 | 58.19% | 行业排名> |
| 2022-12-31 | 1.93% | -62.3% | -1.03% | 32/52 | -1.81% | *ST宜康 | 75.53% | 行业排名> |
| 2022-09-30 | 1.95% | -10.55% | 72.57% | 36/52 | 11.4% | 博腾股份 | 39.77% | 行业排名> |
| 2022-06-30 | 1.13% | -8.13% | -13.08% | 36/52 | 5.56% | 睿智医药 | 41.16% | 行业排名> |
| 2022-03-31 | 1.3% | 2% | -74.61% | 27/52 | 3.14% | 澳洋健康 | 51.68% | 行业排名> |
| 2021-12-31 | 5.12% | -65.15% | 134.86% | 34/52 | -7.44% | 澳洋健康 | 40.93% | 行业排名> |
| 2021-09-30 | 2.18% | 2% | 77.24% | 28/52 | 2.3% | 金域医学 | 43.58% | 行业排名> |
| 2021-06-30 | 1.23% | 108.37% | -91.63% | 34/52 | 2.28% | 金域医学 | 35.41% | 行业排名> |
| 2020-12-31 | 14.69% | 128.06% | 128.06% | 23/52 | 10.95% | 阳光诺和 | 26.2% | 行业排名> |
| 2019-12-31 | -52.36% | -50.03% | -256.19% | 48/52 | 65.31% | 金域医学 | 13.23% | 行业排名> |
| 2019-06-30 | -14.7% | -42.17% | 57.88% | 33/52 | 5.65% | 万邦医药 | 52.05% | 行业排名> |
| 2018-12-31 | -34.9% | 2% | -237.52% | 44/52 | -0.6% | 华大基因 | 48.52% | 行业排名> |
| 2018-06-30 | -10.34% | 2% | 2% | 32/52 | 1.51% | 华大基因 | 31.24% | 行业排名> |